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Most Escherichia coli strains live harmlessly in the intestines and rarely cause disease in
healthy individuals. Nonetheless, a number of pathogenic strains can cause diarrhea or
extraintestinal diseases both in healthy and immunocompromised individuals. Diarrheal
illnesses are a severe public health problem and a major cause of morbidity and mortal-
ity  in infants and young children, especially in developing countries. E. coli strains that
cause diarrhea have evolved by acquiring, through horizontal gene transfer, a particular set
of  characteristics that have successfully persisted in the host. According to the group of
virulence determinants acquired, speciﬁc combinations were formed determining the cur-
rently known E. coli pathotypes, which are collectively known as diarrheagenic E. coli. In this
review, we have gathered information on current deﬁnitions, serotypes, lineages, virulence
mechanisms, epidemiology, and diagnosis of the major diarrheagenic E. coli pathotypes.©  2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
an  open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
a major cause of morbidity and mortality in infants and younghe genus Escherichia,  which was named after the Ger-
an pediatrician Theodor Escherich, consists of facultative
naerobic Gram-negative bacilli that belong to the family
nterobacteriaceae.1 The genus type species Escherichia coli is
idely distributed, where it is the major facultative anaerobenhabiting the large intestine of humans and warm-blooded
nimals.2 Although most E. coli strains live harmlessly in
he colon and seldom cause disease in healthy individuals,
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Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)a number of pathogenic strains can cause intestinal and
extraintestinal diseases both in healthy and immunocompro-
mised individuals.3
Diarrheal illnesses are a severe public health problem andchildren.4 Low- and middle-income countries in Africa, Asia
and Latin America are the most affected regions with diarrheal
diseases occurring more  often with lethal outcomes mainly
lsevier Editora Ltda. This is an open access article under the CC
.
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due to poor living conditions (inadequate water supplies,
poor environmental hygiene and sanitation, and insufﬁcient
education).5
E. coli strains involved in diarrheal diseases are one of the
most important of the various etiological agents of diarrhea,
where strains have evolved by the acquisition, through hori-
zontal gene transfer, of a particular set of characteristics that
have successfully persisted in the host.3,5,6 According to the
group of virulence determinants acquired, speciﬁc combina-
tions were formed determining the currently known E. coli
pathotypes, which are collectively known as diarrheagenic
E. coli (DEC).6 The DEC pathotypes differ regarding their prefer-
ential host colonization sites, virulence mechanisms, and the
ensuing clinical symptoms and consequences, and are clas-
siﬁed as enteropathogenic E. coli (EPEC), enterohemorrhagic
(Shiga toxin-producing) E. coli (EHEC/STEC), enteroaggregative
E. coli (EAEC), enterotoxigenic E. coli (ETEC), and enteroinvasive
E. coli (EIEC).
Each of these pathotypes represents a group of clones
that share speciﬁc virulence factors. Nevertheless, it should
be pointed out that the plasticity of the E. coli genome has
hindered the identiﬁcation of certain E. coli isolates as a
pathotype, because some isolates combine the main virulence
characteristics of different pathotypes and are thus consid-
ered potentially more  virulent hybrid pathogenic strains.5
Another less well-deﬁned pathotype has been described,
that is, the diffusely-adherent E. coli (DAEC) pathotype, which
comprises strains that adhere to epithelial cells in a diffused
distribution.6 Despite their classiﬁcation as a group distinct
from the other pathotypes, the designation of DAEC as a differ-
ent DEC pathotype requires further epidemiological studies,
which have been hampered by the difﬁculties in its identiﬁ-
cation and classiﬁcation.5 Furthermore, certain E. coli strains
that have been classiﬁed as the adherent invasive E. coli (AIEC)
pathotype, comprise one of the potential agents for Crohn’s
disease (CD). CD is an inﬂammatory bowel disease (IBD), which
is thought to be caused by a combination of factors (genetics,
the intestinal microbiota, environmental factors, and enteric
pathogens).7,8
Diarrheal episodes due to DEC infections are an important
public health issue among children and adults in develop-
ing countries, because of their association with morbidity and
mortality of children less than ﬁve years of age. It was our aim
with this review to gather information on current deﬁnitions,
serotypes, lineages, virulence mechanisms, epidemiology, and
diagnosis of the major DEC pathotypes with emphasis on the
studies conducted in Brazil.
Typical  and  atypical  enteropathogenic  E.  coli
The term enteropathogenic E. coli (EPEC) was ﬁrst used in
1995 by Neter et al.,9 to describe a number of E. coli strains
epidemiologically related to a series of outbreaks of infantile
diarrhea in the 1940s and 1950s.10,11 Originally identiﬁed by
serotype, EPEC are now deﬁned as those E. coli strains having
the ability to cause diarrhea, to produce a histopathology on
the intestinal epithelium known as the attaching and effac-
ing (AE) lesion, and the inability to produce Shiga toxins and
heat-labile (LT) or heat-stable (ST) enterotoxins.6 b i o l o g y 4 7 S (2 0 1 6) 3–30
Improvements in techniques allowing a better understand-
ing of the genome and virulence mechanisms among EPEC
strains over the years have led to the sub-classiﬁcation of EPEC
into typical EPEC (tEPEC) and atypical EPEC (aEPEC).3,12 Typi-
cal EPEC strains causing human infectious diarrhea possess
a large virulence plasmid known as the EPEC adherence fac-
tor (EAF) plasmid (pEAF), which encodes the type IV ﬁmbriae
called the bundle-forming pilus (BFP), while aEPEC do not
possess this plasmid.6,12
The majority of tEPEC strains fall into well-recognized O
serotypes. Classical EPEC O serogroups include O55, O86, O111,
O114, O119, O127, and O142. The most common H antigens
associated with EPEC are the H6 and H2 antigens.12–15 A less
common EPEC type is H34, and a number of tEPEC strains
are classiﬁed as non-motile (H-) in conventional tests. Typical
EPEC strains belonging to non-classical serotypes have also
been reported.12,16
Based on multilocus enzyme electrophoresis analysis
(MLEE) of allelic differences between housekeeping genes,
tEPEC strains have been subtyped into two  major lineages,
previously designated EPEC1 and EPEC2.13,14 EPEC1 includes
widespread serotypes such as O55:H6 and O119:H6, whereas
EPEC2 consists of serotypes with more  limited occurrence
such as O111:H2 and O114:H2. Based on a whole-genome
phylogeny and analysis of type III secretion system (T3SS)
effectors, tEPEC strains have been demonstrated to cluster
in three main lineages, designated EPEC1, EPEC2, and EPEC4,
which probably acquired the locus of enterocyte effacement
(LEE) region and pEAF independently.17
In turn, aEPEC belong to a large diversity of classical
and non-classical serotypes.12,16,18 Over 20% of strains of
non-classical EPEC serotypes are O non-typeable and the O-
typeable strains belong to more  than 4200 different serotypes,
with many  non-motile and H non-typeable strains.12,18 Inter-
estingly, it has been found that 35% of the aEPEC strains also
belong to the tEPEC lineages.17 Thus, it has been hypothe-
sized that at least some aEPEC may have originated from tEPEC
strains that lost pEAF in the host or in the environment.17,19,20
Virulence  factors,  mechanisms  and  pathogenesis
Typical EPEC strains adhere to HeLa, HEp-2, and other cell lines
and to organ cultures in vitro in a distinctive pattern of three-
dimensional microcolonies, a so-called localized adherence
(LA) pattern.6,21 A similar adherence pattern has been seen
in tissue biopsies of EPEC-infected humans.22
The LA phenotype is mediated by the BFP,23 which
also contributes to antigenicity, autoaggregation, and bioﬁlm
formation.23–27 An operon of 14 genes contained on the pEAF
is necessary for BFP expression, with bfpA encoding the major
structural subunit (bundlin)28 and being highly conserved
among EPEC1 and EPEC2 strains.
The self-transmissible pEAF pMAR2 is found among
strains of the EPEC1 lineage and contains an intact transfer
region, unlike pB171, which is more  common among EPEC2
strains.29,30 Besides the bfp gene cluster, encoding BFP,23 the
pEAF carries the per locus, encoding the transcriptional activa-
tor called plasmid-encoded regulator (Per).29 Between pMAR2
and pB171, the bfp and per loci share 99% sequence similarity,30
and both BFP and PerA have been shown to contribute to
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irulence in human volunteers.24 Recent comparative
enomics of the EAF plasmids from diverse EPEC phyloge-
omic lineages demonstrated signiﬁcant plasmid diversity
ven among isolates within the same phylogenomic lineage.31
Typical EPEC have the ability to form tight, spherical, bac-
erial autoaggregates when grown in liquid culture.32 Like LA,
utoaggregation requires BFP. Typical EPEC also form bioﬁlms
n abiotic surfaces under static conditions, or in a ﬂow through
ontinuous culture system, and a model of EPEC bioﬁlm
ormation has been proposed.26 Mutagenesis analysis has
dentiﬁed adhesive structures such as the common type 1
ilus (T1P), antigen 43, BFP and the EspA ﬁlament (see below)
s participants in bacterial aggregation during bioﬁlm forma-
ion on abiotic surfaces.26
A hallmark phenotype of both tEPEC and aEPEC is the abil-
ty to produce AE lesions.33 This phenotype is characterized
y effacement of intestinal epithelial-cell microvilli and inti-
ate adherence between the bacterium and the epithelial cell
embrane. Directly beneath the adherent bacterium, marked
ytoskeletal changes are seen in the epithelial cell membrane,
articularly the formation of an actin-rich cup-like pedestal at
he site of bacterial contact. AE lesions are observed in model
PEC infections with cultured cells and mucosal explants, as
ell as in intestinal biopsies from EPEC-infected infants or
nimals.6
AE lesions are encoded by LEE, which is a ∼35-kb
athogenicity island (PAI)34 that is organized into ﬁve oper-
ns (LEE1 to LEE5).35–37 The LEE1, LEE2, and LEE3 operons
ncode components of a T3SS, and the global regulator Ler
LEE-encoded regulator).38 LEE4 encodes the T3SS-secreted
roteins EspA, EspB, and EspD (EPEC-secreted protein), which
re components of the translocation apparatus by which other
ffector proteins are translocated into the cell. LEE5 encodes
he adhesin intimin and its translocated receptor, Tir.39
Intimin is a 94-kDa protein encoded by the eae gene and
equired for intimate adherence of EPEC to host cells at the
ites of AE lesions.6 The N-terminus of intimin is highly
onserved, whereas the C-terminus is highly variable.40 Dif-
erences in the C-terminus of intimin have been used as a
asis for classiﬁcation into several distinct subtypes, repre-
ented by the Greek letters  (alpha) through  (zeta)41,42; the 
ubtype is expressed by EPEC1 strains while subtype  is asso-
iated with human EPEC2 strains. The N-terminus of intimin
nchors the protein in the EPEC outer membrane, whereas
he C-terminus extends from the EPEC surface and binds
o the Tir. Intimin–Tir interaction leads to intimate adher-
nce and pedestal formation beneath adherent bacteria,39 and
nhibits NF-B activity through tumor necrosis factor alpha
TNF-) receptor-associated factors.43 In addition to Tir, the
PEC genome contains six other LEE-encoded effector proteins
hat are translocated into the cell (Map, EspF, EspG, EspZ, EspH,
nd EspB), which interfere with different aspects of the cell’s
hysiology.13,36,37,44
In addition to the LEE effectors, various non-LEE (Nle)-
ncoded effector genes (cif, espI/nleA, nleB, nleC, nleD, nleE,
leH)36,44 have been described, which are located outside the
PEC LEE region, in at least six chromosomal PAIs, or in
rophage elements.45,46 The Nle proteins have been shown
o disrupt the cytoskeleton and tight junctions of the host
ell, and to modulate or prevent the host inﬂammatory b i o l o g y 4 7 S (2 0 1 6) 3–30 5
response.45–47 Although they are not required for AE lesion
formation, it is understood that they contribute to increased
bacterial virulence.44
Intracellular tEPEC have been observed both in tissue cul-
ture and in small intestinal biopsies from an EPEC-infected
infant.6 Two studies have reported that O111:NM strains con-
tain plasmid sequences that confer invasiveness upon E. coli
K12 strains containing the cloned fragments.48,49 Sequences
homologous to these cloned genes are present in only a minor-
ity of tEPEC strains (Scaletsky et al., unpublished data).
Typical EPEC strains encode a large surface protein,
lymphocyte inhibitory factor (LifA), which inhibits the expres-
sion of multiple lymphokines and inhibits lymphocyte
proliferation.50 Two related genes efa1 and toxB have been
implicated in adhesion to epithelial cells.51,52 There is evi-
dence indicating that Efa1/LifA contributes to epithelial cell
adherence in vitro53 and is required for intestinal colonization
of mice by the related AE pathogen Citrobacter rodentium.54
Some tEPEC strains possess other ﬁmbriae or pili in addi-
tion to BFP. Type 1 ﬁmbriae of EPEC have been found to be
antigenic in volunteer studies; however, they do not have a role
in adherence to epithelial cells in vitro.6 In addition, some EPEC
strains have conserved ﬁmbrial genes encoding homologs of
long polar ﬁmbriae (LPF),55 but a number of polymorphisms
within the lpfA genes have been identiﬁed.56 Initial stud-
ies have indicated that LPF is apparently not necessary for
adherence and AE lesion in human biopsies.55 The E. coli com-
mon pilus (ECP) has also been shown to act as an accessory
adherence factor in EPEC, playing a role during cell adher-
ence and/or in bacterium-bacterium interactions.57 However,
the signiﬁcance of ECP to EPEC pathogenesis has not been
determined. Interestingly, it has been shown that some tEPEC
strains may produce a hybrid adherence phenotype in HeLa
cells, i.e.,  LA and aggregative (AA)-like pattern concurrently
(LA+/AA-like+).58 Recently, it was shown that at least some of
these LA/AA-like+ strains bear large plasmids, distinct from
the pEAF, that encode a so far unknown adhesin.59 It has
been proposed that the ability of such strains in producing
AE lesions and an AA-associated bioﬁlm concomitantly could
worsen the patient’s clinical condition, leading to persistent
diarrhea.59
Flagella may also be involved in tEPEC adherence to epithe-
lial cells,60 since certain EPEC mutants are markedly impaired
in their ability to adhere and to form microcolonies. Further-
more, in one study, puriﬁed EPEC ﬂagella and anti-ﬂagellum
antibodies were both effective in blocking the adherence of
several EPEC serotypes.60 However, another study could not
conﬁrm the role of ﬂagella in EPEC adherence.61
Some tEPEC strains harbor the astA gene, which encodes
the enteroaggregative E. coli heat-stable enterotoxin 1
(EAST1).62,63 A recent study reported that 11 of 70 (16%) tEPEC
strains tested harbored an intact astA gene.64 Typical EPEC
strains of serotype O86:H34 produce cytolethal-distending
toxin (CDT).65 The signiﬁcance of EAST1 and CDT toxins in
EPEC pathogenesis remains unknown.
Autotransporter (AT) proteins, which have been associ-
ated with bacterial adherence, aggregation, bioﬁlm formation,
invasion, and toxicity66 in Gram-negative bacteria, have also
been described among EPEC strains.67 One such protein, EspC,
which is secreted by the type V secretion system and is
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injected by the T3SS in epithelial cells, has an IgA protease-
like activity and, once in the host cytoplasm, has various
cytopathic effects, including cytoskeletal damage,68 enhanced
lysozyme resistance,70 hemoglobin degradation,69 hydrolysis
of pepsin, factor V, and spectrin,70 and fodrin and focal adhe-
sion protein degradation.71 In addition, oligomerization of
EspC gives rise to rope-like structures that serve as a substra-
tum for adherence and bioﬁlm formation as well as protecting
bacteria from antimicrobial compounds.72
A three-stage model of tEPEC adhesion and pathogen-
esis, consisting of LA, signal transduction, and intimate
attachment with pedestal formation, was proposed.73 Simul-
taneously with intimate attachment, a series of bacterial
effector proteins are injected into host cells, where they sub-
vert actin polymerization and other host cell processes.37,44
In the earliest stage and under correct environmental con-
ditions, tEPEC express BFP, intimin, and the T3SS/translocon
apparatus. Next, EPEC adhere to the surface of the intesti-
nal epithelium via BFP and EspA ﬁlaments, and the T3SS
injects the bacterial translocated intimin receptor (Tir) and
effector proteins (EspB, EspD, EspF, EspG, and Map) directly
into the host cell.37 The effectors activate cell-signaling
pathways, causing alterations in the host cell cytoskele-
ton and resulting in the depolymerization of actin and
the loss of microvilli. Finally, bacteria intimately adhere to
host cell by intimin–Tir interactions, causing a cytoskeletal
rearrangement that results in pedestal-like structures. Tir pro-
motes cytoskeletal reorganization through interaction with
neural WASP (Wiskott-Aldrich syndrome protein) (N-WASP)
and subsequent activation of the Arp2/3 complex,45 lead-
ing to the effacement of the microvilli and the production
of pedestals.44,74 The translocated effectors disrupt host cell
processes, resulting in loss of tight-junction integrity and
mitochondrial function, leading to both electrolyte loss and
eventual cell death.45
For actin dynamics subversion, tEPEC usually recruits
Nck to the adhesion site in a Tir phosphorylated Y474-
dependent mechanism. In turn, TirEHEC (enterohemorrhagic
E. coli [EHEC] O157:H7) is devoid of an Y474 equivalent and
employs EspFU/TccP (Tir-cytoskeleton coupling protein), a
T3SS-translocated effector protein that binds N-WASP, leading
to Nck-independent actin polymerization.45
aEPEC are devoid of pEAF and do not produce BFP. It is
important to point out that EPEC strains of serotypes O128:H2
and O119:H2 contain a pEAF with defective bfp operons, which
contain part of the bfpA gene but have the rest of the bfp
gene cluster deleted. Thus, they are classiﬁed as aEPEC.12,75
Most aEPEC produce adherence patterns categorized as LA-
like, with loosened microcolonies compared to those of the
tEPEC LA pattern.12,76,77 In addition, some isolates express
the aggregative (AA) or diffuse (DA) patterns of adherence,
which are characteristics of the EAEC and DAEC pathotypes,
respectively,20,78 or adhere in undeﬁned patterns or are non-
adherent.20,78–80 Remarkably, the epithelial cell adherence
phenotype displayed by aEPEC is determined in prolonged
assays (6 h) of bacteria-cell interaction.12,76,77 In addition, it
has been suggested that lack of the pEAF-encoded Per pro-
teins in the regulatory cascade of the aEPEC virulence genes
may promote delayed AE lesion formation, probably making it
difﬁcult for such strains to cause disease.81 b i o l o g y 4 7 S (2 0 1 6) 3–30
The prevalence of intimin subtypes among aEPEC strains
has been reviewed.18,67 Intimins classiﬁed as beta1, epsilon1
and theta appear as the most frequent among aEPEC.78,82–85 In
addition, some aEPEC strains bear adhesive-encoding genes
that have been originally described in other DEC pathotypes
and/or in extraintestinal pathogenic E. coli.79,80,82,86–88 This
observation suggests that aEPEC could employ additional
adherence mechanisms besides the Tir-intimin interaction.
The only adhesin ﬁrst characterized in an aEPEC strain
(serotype O26:H11) is the locus of diffuse adherence (LDA), which
is an aﬁmbrial adhesin that confers the diffuse pattern of
adherence on HEp-2 cells, when cloned in E. coli K-12 strains.89
The T3SS-translocon has been also shown to contribute to the
adherence efﬁcacy of an aEPEC strain in vitro.90 The prevalence
of these different adhesins among aEPEC has been recently
reviewed.18,67,91
Moreover, it has been recently shown that the ﬂagellar
cap protein FliD of an aEPEC strain (serotype O51:H40) binds
to unknown receptors on intestinal Caco-2 cell microvilli.92
Interestingly, an anti-FliD serum and puriﬁed FliD reduced
adherence of the aEPEC as well as that of tEPEC, EHEC and ETEC
prototype strains to the same cell line.92 Furthermore, it has
been suggested that adherence of aEPEC of serotype O26:H11
may be mediated by binding of the ﬂagellin protein FliC (the
subunit of the ﬂagella shaft) to cellular ﬁbronectin.93 However,
the role of the ﬂagella in aEPEC in vivo colonization has yet to
be investigated.
Atypical EPEC strains have also been shown to adhere to
abiotic surfaces (polystyrene and glass).94,95 The non-ﬁmbrial
adhesin curli and the T1P have been shown to mediate binding
to these surfaces in some aEPEC at different temperatures.90,96
The LEE region of some aEPEC strains display a genetic
organization similar to that found in the tEPEC prototype
E2348/69 strain.97 Although the T3SS-encoding genes are con-
siderably conserved,97,98 the effector protein-encoding genes
display important differences, and remarkable differences can
be detected at the 5′ and 3′ ﬂanking regions of aEPEC, suggest-
ing the occurrence of different evolutionary events.99 Atypical
EPEC strains may carry two tccP variants, tccP and/or tccP2, sug-
gesting that some aEPEC strains may use both Tir-Nck and
Tir-TccP pathways to promote actin polymerization.100 Inter-
estingly, Rocha and colleagues101 showed that transformation
of a non-adherent aEPEC strain (serotype O88:HNM) with a
TccP expressing-plasmid, conferred this strain the ability to
adhere to and to induce actin-accumulation in HeLa cells.
The occurrence and prevalence of Nle in aEPEC strains have
been recently reviewed.67 It has been suggested that differ-
ent isolates can employ distinct strategies to promote damage
to the host and cause disease.45 In addition, the Nle effec-
tors Ibe (invasion of endothelial cells) and EspT have been
originally described and characterized in aEPEC strains.102,103
Ibe appears to regulate Tir phosphorylation and to enhance
actin polymerization and pedestal formation,103 while EspT104
modulates actin dynamics, leading to membrane rufﬂing and
cell invasion, and induces macrophages to produce inter-
leukins IL-8 and IL-1 and PGE2.102Invasion of epithelial cells in vitro in an intimin-dependent
pathway has been described in an aEPEC strain,105 but further
studies pointed out that the invasive phenotype is not a com-
mon  characteristic among aEPEC.106 Despite their invasive
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otential in vitro,107 most aEPEC are considered extracellular
athogens.5
It has been shown that apical infection of cultured human
ucin-secreting intestinal HT29-MTX cells by some aEPEC
trains may induce increased production of secreted MUC2
nd MUC5AC mucins and membrane-bound MUC3 and MUC4
ucins.108 This observation suggests that the apically adher-
ng bacteria could exploit large amounts of mucins to grow
ore  efﬁciently in the host intestines, characterizing a puta-
ive new virulence mechanism in aEPEC.108
AT proteins have also been shown to be produced by some
EPEC strains.67 Abreu and collegues109 have shown that the
T protein encoded by the ehaC gene, which is involved in
ioﬁlm formation in EHEC strains, was the most frequent, with
 signiﬁcantly higher prevalence than in tEPEC. Although the
revalence of the AT protein Pic (protein involved in intestinal
olonization), formerly identiﬁed in EAEC, is not a common
nding in aEPEC strains, it also appears to mediate coloniza-
ion of mouse intestines, hemagglutination, mucin cleavage,
nd complement components degradation.110 More recently,
ome aEPEC strains were shown to cause cell damage by
ecreting the AT protein Pet (plasmid encoded toxin) to the
xtracellular environment.111
pidemiology
he prevalence of EPEC infections varies between epidemio-
ogical studies on the basis of differences in study populations,
ge distributions, and methods (serotyping, adherence pat-
erns, and presence of the eae or conserved LEE genes) used
or detection and diagnosis.112 In addition, differences in geo-
raphic regions, periods of time and socioeconomic class may
lso contribute to differences in the epidemiology of EPEC-
nduced diarrheal disease.113 Lack of discrimination between
EPEC and aEPEC in some studies also makes such analysis
ifﬁcult.
Diarrhea due to tEPEC decreases with age, and infections in
dults are rarely reported. This apparent resistance in adults
nd older children has been attributed to the loss of speciﬁc
eceptors with age or development of immunity.6
For many  decades, studies conducted worldwide have
hown that tEPEC serotypes are strongly associated with diar-
hea in children <1 year of age, mainly in poor children in
rban centers.6,12,15 The association with diarrhea was partic-
larly strong in infants less than 6 months of age. Studies in
razil, Chile, Mexico, and South Africa, showed that 30–40% of
nfantile diarrhea cases were due to tEPEC serotypes.15,112,114
owever, the epidemiology of EPEC infections has shifted.
n numerous developing countries, where the prevalence of
PEC infection had been high until the 1990s, recent studies
ave not identiﬁed a signiﬁcant association between tEPEC
nd infantile diarrhea. In Brazil, 92% of EPEC isolates col-
ected from children between 2001 and 2002 were atypical,115
ompared to 38% in a 1998–1999 study.79 However, other stud-
es still report tEPEC being more  prevalent than aEPEC as a
ause of diarrhea.116 In addition, in some less developed areas
Africa and Asia), tEPEC are still some of the most impor-
ant enteropathogens.117–122 Based on the recently completed
lobal Enteric Multicenter Study (GEMS) involving children b i o l o g y 4 7 S (2 0 1 6) 3–30 7
less than 5 years of age from seven sites in Africa and Asia,
tEPEC was signiﬁcantly associated with moderate to severe
diarrhea in children under 2 years of age in Kenya, whereas
aEPEC was not associated with this type of diarrhea.118
Transmission of tEPEC follows a fecal-oral process
through contaminated surfaces, weaning ﬂuids, and human
carriers.123 Although rare, outbreaks among adults seem
to occur through the ingestion of contaminated food and
water; however, no speciﬁc environmental reservoir has been
identiﬁed.6 The infective dose in adult volunteers is high, at
108 to 1010 organisms,124 while the infective dose that causes
disease in children is unknown. EPEC outbreaks have been
reported to show a seasonal distribution with peaks during
the warm months.6,125 Humans are the only known reservoir
for tEPEC, with symptomatic and asymptomatic children and
asymptomatic adults being the most likely source.6
In contrast to tEPEC, aEPEC have been found in diarrheic
patients of all ages and in adults with HIV-AIDS.82,126–128 Fur-
thermore, the proportion of aEPEC strains has increased, and
aEPEC strains have outnumbered tEPEC strains and have also
been associated with childhood diarrhea in some developing
and developed countries.12,18,67,91,112,129 However, the increase
in prevalence of aEPEC may also reﬂect the reﬁned discrimi-
nation between tEPEC and aEPEC.12,18,91
The role of aEPEC in diarrhea is not clear because of its
detection at similar rates in both diarrheic and non-diarrheic
patients in various geographical areas.18,91,128 In studies con-
ducted in the last ﬁve years, aEPEC have been found at
rates varying from ∼0.05 to ∼12% in diarrheic versus 0 to
∼14% in non-diarrheic patients.67 Some recent studies have
also implicated aEPEC as the cause of persistent and bloody
diarrhea.18,91 Moreover, aEPEC strains have been associated
with diarrheal outbreaks in Finland, United States, Japan,
China18,91,112 and Brazil.85
In contrast to tEPEC, which are seldom found in animals,12
many  aEPEC strains have been found in both diarrheic and
healthy animals.18,67 Interestingly, animal aEPEC serogroups
associated with human diarrhea have been identiﬁed (e.g.,
O26, O103, O119, O128, O142 and O157).18,130,131 Serotyping
and molecular methods such as multilocus sequence typing
(MSLT) and pulsed ﬁeld gel electrophoresis (PFGE) have con-
tributed to demonstrating that domestic and wild animals and
the environment are potential sources of aEPEC for human
infections in several regions.18,67,91,131 Therefore, although no
direct transmission from animals to humans has been shown
so far, it is reasonable to suggest that some aEPEC strains are
potentially zoonotic pathogens, with a large variety of ani-
mal species serving as important reservoirs.67,91 In addition,
foods including raw meat, pasteurized milk and vegetables
and water have also been implicated as vehicles of aEPEC in
human infections.67
aEPEC strains comprise a very assorted group with various
additional virulence mechanisms that altogether can modu-
late the disease outcome or their occurrence in asymptomatic
persons. There have been continuous advances in our knowl-
edge of the genetic background and pathogenicity of aEPEC
as well as in the information gathered from epidemiological
studies, and may contribute to the discrimination between
strains that cause diarrhea and those that cause asymp-
tomatic infections.
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Detection  and  diagnosis
EPEC can be detected by DNA probes or PCR assays using
primers targeting the eae and stx genes.132,133 All eae-positive
and stx-negative E. coli strains are further tested by PCR for
the presence of the bfpA gene encoding bundlin6 and/or the
EAF plasmid to differentiate tEPEC from aEPEC.134,135 How-
ever, this may fail to identify all bfpA-positive EPEC strains,
since multiple alleles of bfpA have been identiﬁed,136 suggest-
ing that some current PCR methods may fail to identify all
bfpA-positive EPEC strains.
However, in routine microbiology laboratories, all E. coli
colonies obtained from primary isolation plates are tradition-
ally screened by slide agglutination assays using sera against
the classical EPEC serogroups O26, O55, O86, O111, O114, O119,
O125, O126, O127, O128, O142, and O158.137 This method is
practical and easy to perform, the main advantage of which is
the commercial availability of the sera. However, the disadvan-
tage of this method is the heterogeneity of EPEC serogroups
that can comprise categories other than EPEC, the inability to
distinguish tEPEC from aEPEC within these serogroups, and
the occurrence of EPEC strains belonging to serogroups other
than the classical EPEC serogroups.12,18,138,139
Since EPEC strains are deﬁned based on their virulence
properties, a set of proteins, including intimin, BFP and T3SS
secreted proteins can be considered targets for diagnosis. BFP
expression has been considered the phenotypic marker of
tEPEC.18,78,140 Immunoﬂuorescence and immunoblotting tests
using monoclonal or polyclonal antibodies against BFP have
been employed.141,142 These cited authors detected the pro-
duction of BFP on different media, in which they reported
that 91% of the tEPEC strains tested produced BFP in Dul-
becco’s Modiﬁed Eagle Medium (DMEM), 89% in MacConkey,
and 83% in EMB  agars. These results are particularly inter-
esting, since MacConkey and EMB  agars are routinely used
for the identiﬁcation of lactose-fermenting E. coli isolated
from diarrheal stools. A colony immunoblot assay for tEPEC
detection based on BFP expression was also standardized
using a rabbit tEPEC anti-BFP polyclonal serum. Standardiza-
tion was done after growing the bacterial isolates on DMEM
agar containing fetal bovine serum or tryptic soy agar con-
taining 5% washed sheep blood (TSAB). This test showed a
positivity of 92 and 83% and speciﬁcity of 96 and 97%, respec-
tively, when the culture was done in DMEM and TSAB. This
method combines the simplicity of an immunoserological
assay with the high efﬁciency of testing a large number of EPEC
colonies.140
Concerning intimin detection, a rabbit polyclonal sera
raised against the conserved region of intimin (Int388-667)143
was employed in order to detect tEPEC isolates expressing ,
, ,  and  intimin reported an application of immunoblot-
ting with 100% speciﬁcity and 97% sensitivity in the detection
of eae positive E. coli strains.144–146 These authors clearly
demonstrated that polyclonal rabbit antisera is suitable for
immunoblotting as a diagnostic tool, and showed that protein
denaturation and linearization is a critical step for anti-
intimin antibody accessibility. Indeed, even employing the
recombinant antibody such as single chain fragment variable
(scFv-intimin),147,148 merely by immunoﬂuorescence the scFv-
intimin was able to detect tEPEC, aEPEC, and EHEC isolates, b i o l o g y 4 7 S (2 0 1 6) 3–30
showing that intimin can be a target for EPEC and EHEC diag-
nosis after bacterial permeabilization.148
Regarding secreted proteins, Lu et al.149 developed a new
practical method to identify EPEC by detecting the E. coli
secreted protein B (EspB) in the culture supernatant by
reversed passive latex agglutination (RPLA), after the strains
have been cultivated in DMEM. In addition, Nakasone et al.,150
established a rapid immunochromatographic (IC) test to iden-
tify the presence of EspB in EPEC and EHEC isolates. The
detection limit of the test has been reported to be 4 ng/mL, and
the results showed 96.9% sensitivity and 100% speciﬁcity. The
IC test for the detection of EspB may be a practical method
to deﬁne EPEC or EHEC both in clinical laboratories and the
ﬁeld.150
In addition, a rapid agglutination test using latex beads
coated with anti-EspB mAb  was standardized, showing 97%
sensitivity, 98% speciﬁcity and 97% efﬁciency, which is
required for the diagnosis of enteropathogenic diseases and
can be employed in developing countries with poorly equipped
laboratories.151
Enterohemorrhagic  (Shiga  toxin-producing)
E.  coli  (EHEC/STEC)
EHEC/STEC represent a well-known group of foodborne
pathogens distributed worldwide. The ability to produce one
or more  of the Shiga toxin (Stx) family cytotoxins152 con-
stitutes the main virulence attribute of this pathogroup of
E. coli. A wide array of infections from mild and almost
unapparent diarrhea to more  serious manifestations such
as hemorrhagic colitis (HC) and the development of a life-
threatening syndrome known as hemolytic uremic syndrome
(HUS) are caused by EHEC/STEC. Infants and children are the
main affected patients, and although the incidence of infec-
tion varies in different regions, the impact and importance
of EHEC/STEC infections in public health is immense, being
the main cause of acute renal failure in children in many
countries. The perspective of EHEC/STEC infections has been
previously described,153,154 but a considerable amount of infor-
mation has been obtained in more  recent years related to the
epidemiology, ecology and virulence properties of these bacte-
ria.
E. coli O157:H7 serotype was the ﬁrst to be linked to HC
and HUS cases in the early 1980s, and has been since then
responsible for numerous outbreaks and sporadic cases of
severe diseases all over the world, therefore considered to be
the prototype of this pathogenic group of bacteria.155 It is well
known that hundreds of other E. coli serotypes can harbor the
stx genes, but epidemiological studies carried out worldwide
have proven that only some of them have been responsible
for causing human diseases. Some serogroups including O26,
O45, O103, O111, O121 and O145 can be highlighted among
those most commonly related to human infections.156 More-
over, in recent years the emergence of some particular clonesStx2 genes, responsible for a severe outbreak of HUS start-
ing in Germany in 2011,157 the spread of a new O26:H11 clone
in Europe,158 and some other hybrid clones,159 suggests that
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he mobility of genes and certainly the host background are
mportant features implicated in their pathogenic potential.
irulence  factors,  mechanisms  and  pathogenesis
he common feature among EHEC/STEC isolates is the abil-
ty to produce Stx. This family of toxins has a conserved
B5 subunit structure, composed of one active A subunit
inked to a pentameric B subunit responsible for the bind-
ng of the toxin to speciﬁc glycolipid receptors on the surface
f target cells. The stx operon is usually found within the
equence for an inducible, lysogenic, lambda-like bacterio-
hage. Stxs inhibit protein synthesis by removing an adenine
esidue from the 28S rRNA of the 60S ribosome.152 However,
esides this activity, studies have described that Stx also acts
n cell signal transduction and immune modulation causing
roinﬂammatory and pro-apoptotic responses.159 Two major
amilies, Stx1 and Stx2, have been recognized, and on the
asis of sequence diversity, each is composed of several vari-
nts. The Stx1 family is more  homogenous and includes Stx1a,
tx1c and Stx1d; while the heterogenous Stx2 group is com-
osed of Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g.160
t should be mentioned that the association of some vari-
nts such as Stx2a, Stx2c or Stx2d with HC and HUS has
een highlighted compared to some others that seemed to
e more  related to uncomplicated cases of diarrhea such as
tx1variants or even Stx2e, Stx2f and Stx2g, which are uncom-
only found causing human infections so far.161,162 Indeed,
he higher association of Stx2 with severe diseases has been
xtensively studied by using Vero and endothelial cell lines
s well as some animal models.159 Moreover, knowledge of
tx phage characteristics and behavior has helped our under-
tanding of how differences in expression of Stx between
HEC/STEC isolates may contribute to pathogenesis and
isease.163
The ability to adhere to intestinal epithelial cells is
nother key event in EHEC/STEC pathogenesis. The pres-
nce of the chromosomal pathogenicity island LEE,164 also
resent in isolates belonging to the EPEC pathotype, is
ommon. Although LEE has been described in the major
HEC/STEC serotypes responsible for a high proportion of
C and HUS cases in several countries, its presence is not a
equired condition for the occurrence of more  serious infec-
ions as initially thought, because some LEE-negative strains
re also capable of causing outbreaks and sporadic cases of
US.165,166
Therefore, it is clear that EHEC/STEC pathogenesis is a mul-
istep process, and besides the production of Stx toxins and
he AE lesion, other factors including different types of toxins
nd adhesins have been described and found to be involved in
irulence.159
One should also consider that as a pathogen of the
uman gastrointestinal tract the ability of EHEC/STEC
o monitor nutrients in the gut milieu, and translate
his information to sense the host physiological state in
rder to program the expression of its virulence mark-
rs has a pivotal role on the development of infection.167
n addition, it has been shown that EHEC/STEC can
lso cross-communicate with the host by exploiting the
utoinducer-3 (AI-3)/epinephrine/norepinephrine signaling b i o l o g y 4 7 S (2 0 1 6) 3–30 9
system to express two important virulence traits, motility and
A/E lesion, required at different time points during intestinal
colonization.168
The ability to adhere, colonize and form bioﬁlm on food
and several types of surfaces may be a way to be an impor-
tant source and/or vehicle of transmission of EHEC/STEC. In
addition, bioﬁlm may also act as bacterial protection against
adverse environmental conditions. A study conducted by Bis-
cola et al.,169 evaluated the capacity of bioﬁlm formation
in EHEC/STEC strains isolated from different reservoirs and
serotypes. The authors observed that the ability to adhere
to abiotic surfaces forming bioﬁlms, under deﬁned culture
conditions, occurred in an array of wild-type O157 and non-
O157 strains. Bioﬁlm production was identiﬁed in several
non-O157 STEC serotypes of human, animal, and food ori-
gin. On the other hand, among the O157 strains, only those
isolated from the animal reservoir and from a water sample
produced bioﬁlm. A close correlation between bioﬁlm for-
mation and expression of curli ﬁmbriae and cellulose was
observed among O157 strains. However, in addition to curli,
the presence of other factors such as type 1 ﬁmbriae and AT
proteins may be associated with the ability to form bioﬁlm in
non-O157 strains. Matheus-Guimarães et al.,170 studied O157
and non-O157 EHEC/STEC strains isolated from bovine hides
and carcasses and showed that different sets of genes were
involved in the interactions of the bacteria with biotic and
abiotic surfaces. Moreover, the detection of an O157 strain
that was able to form bioﬁlm on both glass and polystyrene
and that adhered to and invaded human cells, suggests an
important ability of this isolate to persist in the environment
and interact with the host. In fact, cell invasion and sur-
vival of some EHEC/STEC strains in cultured human intestinal
epithelial cells has been previously described.171 It should be
mentioned that this invasive characteristic has been identiﬁed
in some EHEC/STEC serotypes, many  of which are responsi-
ble for human infections.170–173 Therefore, it is conceivable
that this virulence strategy may help bacteria to overcome
host defense mechanisms and certainly contributes to their
persistence in the zoonotic reservoir, ensuring efﬁcient envi-
ronmental and food transmission.
Another topic of interest has been the analysis and com-
parison of the virulence proﬁle of EHEC/STEC strains isolated
from the animal reservoir and environment with strains recov-
ered from human infections. In general, these studies have
shown that despite serotype diversity, the stx subtypes and
the virulence proﬁle identiﬁed among isolates from the animal
reservoir and environment are similar to the isolates recov-
ered from patients.173,178–180 There has been particular interest
in some STEC serotypes that have been responsible for causing
severe human infections, such as O113:H21, but unlike others,
they do not produce adhesins encoded by LEE. By using a PCR
microarray, 41 virulence or genetic markers were tested in a
panel of 65 O113:H21 strains isolated from clinical infections,
environment and food from various countries.174 The results
obtained showed no clear differences in these genetic mark-
ers between the pathogens recovered from HUS  cases and the
environmental strains. Moreover, only stx subtypes associated
with human infections were identiﬁed in all isolates, therefore
suggesting that the environmental isolates have the potential
to cause human diseases.
 i c r o
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Epidemiology
The incidence of HUS cases in Brazil is low,175 and although
some hypothesis has been proposed to explain this fact, there
are limited data on the immune response against Stx. In an
attempt to overcome this gap, prevalence of anti-Stx2 anti-
bodies in sera of children diagnosed with HUS and of healthy
children was recently determined.176 The percentage of indi-
viduals showing antibodies against Stx2 was higher among
HUS patients than controls, and the results also conﬁrmed
that STEC strains are circulating in our settings despite the
low number of identiﬁed HUS cases.
Among the several serotypes associated with human
infections, O157:H7 is responsible for more  severe cases. Epi-
demiological investigations of diarrheal outbreaks conducted
in four Brazilian states showed that O157:H7 strains were iso-
lated from two hospitalized patients, one with HUS and the
other with bloody diarrhea.177 Besides, O157:H7, EHEC/STEC
strains belonging to the top six most important non-O157
serogroups such as O26, O103, O111 and O145 were identi-
ﬁed, all of which were recovered from ambulatory patients.
In addition, some uncommon serogroups including O1, O24
and O77 among others were also detected, but they were
all associated with acute diarrhea. It is interesting to note
that the majority of patients from whom STEC was isolated
were female (57%), and that patients’ ages ranged from 8
months to 80 years, with most being less than ﬁve years old
(54%).177
The distribution of EHEC/STEC in the gastrointestinal tract
of a wide variety of animals indicates the zoonotic charac-
ter of its infections. The role of different animal species as
asymptomatic carriers of EHEC/STEC has been extensively
studied in the last years in Brazil. Besides cattle, which
are their most common natural reservoir,173,178 the pres-
ence of these pathogens has been identiﬁed in the feces
of dairy buffaloes,179 sheep,180,181 pigs,182,183 birds,184 and
ﬁshes.185 It is noteworthy that some relevant serotypes linked
to human infections such as O103:H2 and O157:H7 have
been recovered from the feces of sheep186 and cattle173
respectively. Additionally, the high prevalence of O157:H7
EHEC/STEC strains identiﬁed in hides of cattle sent to
slaughter in a Brazilian processing plant178 certainly rep-
resents a relevant issue that should be considered when
thinking about interventions targeting EHEC/STEC related to
animal handling, from farm to slaughter, as well as the
implementation of food safety throughout production and
processing.
The presence of EHEC/STEC in the environment is another
issue of concern, since they can survive in the soil, manure,
pastures and water, which thus represent important vehicles
of transmission. The isolation of STEC strains from drink-
ing water supplies, collected in different municipalities in
northern Paraná State, has been recently described, highlight-
ing the importance of drinking water, especially that from
untreated water supplies, as a source of STEC strains poten-
tially pathogenic for humans.187 Taking into account that
chicken litter is very useful as an organic soil fertilizer for the
production of fruits and vegetables in our settings, the detec-
tion of STEC in organic chicken fertilizer used on farms188 also
represents a signiﬁcant public health safety hazard. b i o l o g y 4 7 S (2 0 1 6) 3–30
Although data on the detection of EHEC/STEC in foods
in Brazil are still scarce, the isolation and identiﬁcation of
O157:H7 serotype from a ground beef sample was described for
the ﬁrst time,189 while O125:H19 and O149:H8 STEC serotypes
were found in refrigerated raw kibbe collected from retail
establishments.190 On the other hand, EHEC/STEC has not
been detected in pasteurized cow’s milk samples collected in
dairies in northwestern Paraná State191 or in raw milk, pas-
teurized milk, Minas Frescal cheese and ground beef samples
collected in Minas Gerais.192 One should be aware that despite
difﬁculties in the detection and isolation of EHEC/STEC from
foods, the implementation of the most sensitive methods in
most laboratories should be the main goal in the near future
to help in the analysis of the risk posed by foods as vehicles of
STEC transmission to humans.
Detection  and  diagnosis
An important concern is how to detect Shiga toxin-producing
strains either in stools of infected patients or contaminated
food, since selective enrichment is necessary.193,194 For rou-
tine diagnosis, some protocols have already been described.139
However, the gold standard for Stx detection is still the eval-
uation of the cytotoxicity of bacterial culture supernatants
to eukaryotic cells.195,196 Thus, multiplex PCR including stx
gene and other virulence genes could be useful in screening
for STEC using bacterial conﬂuent growth zones or sor-
bitol fermenting and non-fermenting colonies taken from
SMAC.197
Numerous assays for the diagnosis of STEC have been
developed on the basis of the detection of Stx1 and/or
Stx2, which represents the major virulence factors of this
E. coli category.198 Sensitivities and speciﬁcities vary according
to the test format and the manufacturer.199–205 Neverthe-
less, the standard by which each manufacturer evaluates its
tests also varies; therefore, a direct comparison of perfor-
mance characteristics of various immunoassays has not been
performed.198,206,207 Moreover, these commercially available
tests are not affordable for developing countries. Thus, to out-
line this, previous works have established different formats of
immunoassays, employing either a mixture of rabbit anti-Stx1
and anti-Stx2 sera by indirect ELISA or polyclonal and mono-
clonal antibodies in a capture ELISA assay for the detection of
STEC.207–209 The standardized methods are reproducible, fast,
easy to perform, showing high sensitivity in detecting Stx by
capture ELISA, even in low-producing isolates. These assays
have not yet been evaluated in terms of industrial quality con-
trol and commercial availability, but the estimated cost of the
assay is around US$70 per 96 detections, which is realistically
inexpensive for developing countries.
These monoclonal antibodies were rebuilt resulting in sin-
gle chain fragment variable (scFv) fragments. Stx2-scFv was
obtained from a bacteria-induced culture and showed diag-
nostic ability; the scFv fragment was able to recognize theobserved with the non-producing strains, indicating as high
as 100% speciﬁcity (conﬁdence interval of 86.8–100%).210 It is
worth mentioning that none of the commercially available
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mmunoenzymatic tests for Stx1/2 toxin detection employ
ecombinant antibodies produced in bacteria, which indeed
ill reduce the costs of the diagnostic assays.198
nteroaggregative  E.  coli
AEC is the diarrheagenic E. coli pathotype deﬁned by showing
he characteristic AA pattern on epithelial cells in culture.211
he AA pattern was deﬁned in 1987 when Nataro et al.,212 dis-
inguished the previously described “diffuse adherence” as the
ruly diffuse adherence (DA) and the AA pattern. The standard
A was characterized by adherent bacteria in a stacked-brick
rrangement on the surface of epithelial cells and also on
he coverslip between cells. Strains displaying the AA pat-
ern were then categorized as “enteroadherent-aggregative
. coli” but afterwards the category was called enteroaggrega-
ive E. coli or EAEC, the current nomenclature. The detection
f AA in vitro is still the gold standard test to deﬁne EAEC;
owever, as described before, the AA pattern may be found
n strains of other DEC pathotypes, such as aEPEC. Therefore,
n up-to-date deﬁnition of EAEC is the diarrheagenic E. coli
hat produce AA in cultured epithelial cells but lack the main
enetic markers that deﬁne other DEC pathotypes (EPEC, ETEC,
HEC, EIEC). An exception for that is the hybrid EAEC/STEC
train responsible for a massive outbreak of diarrhea and HUS
n 2011 in Europe.213 This strain consists of an EAEC strain
hat acquired the Stx2-encoding phage. Therefore, this speciﬁc
104:H4 strain is a Stx-producing EAEC.
Diarrhea caused by EAEC is watery, often with the pres-
nce of mucus, with or without blood and abdominal pain,
omiting and low fever. Acute self-limiting diarrhea is the
sual pathology, but some patients may develop protracted
iarrhea, i.e.,  lasting more  than 14 days.214 Prolonged diar-
hea occurs depending on the host’s immunity, nutritional
tatus and genetic susceptibility.215 Genetic susceptibilities
ssociated with EAEC diarrhea were identiﬁed in North Amer-
can travelers to Mexico. Single nucleotide polymorphisms
SNP) in the IL-8 gene promoter and the promotor regions
f the genes encoding lactoferrin, CD14 and osteoprotegerin
s well were recognized as indicators for symptomatic EAEC
nfection.216–219
A well-described characteristic of EAEC strains is their
eterogeneous nature when serotypes, genetic markers of
irulence and phylogenetic groups are analyzed.220–225 This
ndicates that only EAEC strains carrying speciﬁc virulence
actors are able to cause diarrhea. While these factors are
nknown, some studies have demonstrated the association
f speciﬁc virulence genes with diarrhea, such as pet or aafA
n Brazil226 and sepA in Mali.223
irulence  factors,  mechanisms  and  pathogenesis
ost of our knowledge about EAEC pathogenesis is based on
ata accumulated from studies with EAEC strain 042, since
ts association with human diarrhea in a volunteer study.227
hese putative virulence factors include adhesins, toxins and
ecreted proteins. However, none of these factors are found in
ll EAEC strains. i o l o g y 4 7 S (2 0 1 6) 3–30 11
The majority of these virulence factors are plasmid borne,
including those mediating AA. Consequently, these high-
molecular-weight plasmids are called pAA.220 Baudry et al.,228
developed a genetic probe (CVD432) for EAEC diagnosis on the
basis of a fragment from pAA1 present in EAEC strain 17-2.
In EAEC 042, many  putative virulence factors are present in
pAA2.220
Recently, a division of EAEC strains into typical or atypi-
cal subgroups was proposed. This classiﬁcation is based on
the presence or absence of aggR, a gene that encodes a global
regulator of EAEC virulence genes.229 Therefore, it has been
proposed that typical EAEC have more  pathogenic potential
by the presence of the AggR regulon and, consequently, pAA
virulence factors.230 However, at least two outbreaks of diar-
rhea were caused by atypical EAEC,231,232 and atypical EAEC
are commonly isolated from children with diarrhea, in some
cases more  frequently than typical strains.233,234
Numerous adhesins, cytotoxins, enterotoxins and secreted
proteins have been characterized in EAEC strains since this
pathotype deﬁnition.211,214
The most studied adhesins are the aggregative adherence
ﬁmbria (AAF/I-AAF/V) family, which includes ﬁve types.235–239
They mediate the AA pattern and bioﬁlm formation. Aﬁmbrial
adhesins have also been characterized in EAEC strains, includ-
ing outer membrane proteins between 30 and 58 kDa.240–242
However, it has been shown that these structures are
present in low frequencies in EAEC collections from different
settings.221,226,243–245
Located in pAA2 of EAEC 042 is the aap gene, encoding
an antiaggregation protein called dispersin.246 This protein
is secreted and linked to lipopolysaccharide, neutralizing
the negative charge of the bacterial surface leading to AAF
projection and consequent dispersion along the intestinal
mucosa.247 Although immunogenic, dispersin is found in
other E. coli pathotypes and in commensal E. coli.248
Various toxins have been described in EAEC in association
with the cytotoxic or enterotoxic effects of culture super-
natants in vitro. The heat-stable toxin enteroaggregative E. coli
heat-stable enterotoxin 1 (EAST-1) was the ﬁrst toxin charac-
terized in the EAEC pathotype.249 EAST-1 activates adenylate
cyclase inducing increased cyclic GMP  levels, effects observed
in a Ussing chamber with rabbit ileum.250 ShET1 is an A:B type
toxin that causes accumulation of ﬂuid in rabbit ileal loops and
has secretory response in Ussing chamber assays.251,252
The two AT proteins characterized in EAEC 042, Pet and
Pic,253–254 are members of the serine protease autotrans-
porters of Enterobacteriaceae, or SPATE.255 Pet is a cytotoxin
that modiﬁes the cytoskeleton of enterocytes, leading to
rounding and cell detachment. The cytotoxic mechanism of
Pet arises from the degradation of -fodrin, a membrane pro-
tein of the enterocytes.256 Pic is a multitask protein that
mediates hemagglutination, mucus cleavage and hypersecre-
tion, intestinal colonization in mice, cleavage of surface
glycoproteins involved in leukocyte trafﬁcking and cleavage of
key complement molecules.257,258 The phenotypes identiﬁed
for Pic suggest its role in promoting colonization of the intes-
tine and immune system evasion. SPATEs are immunogenic
proteins, as evidenced by the presence of serum antibod-
ies against Pet and Pic in children recovering from diarrhea
caused by EAEC.259
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In the years that followed the deﬁnition of EAEC as
a pathotype, research in the ﬁeld was dedicated to prove
the pathogenic capacity of EAEC using different animal
models260–262 and human volunteers receiving oral inoculum
of different EAEC strains.227,235,263 Not all volunteers devel-
oped diarrhea after ingestion of different EAEC strains, the
ﬁrst evidence that strains of this pathotype are heterogeneous.
Among the strains tested, EAEC 042 (serotype O44:H18) caused
diarrhea in three out of ﬁve volunteers.227 Since then, strain
042 has been considered the prototype EAEC strain and is cer-
tainly the most studied strain of the pathotype.264 EAEC 042
was isolated from a case of acute infantile diarrhea in Peru.265
The clinical data obtained from the volunteers who developed
diarrhea suggested that EAEC 042 caused secretory diarrhea,
with abundant presence of mucus and absence of blood in the
stool.
Studies employing different EAEC strains interacting with
intestinal cells from animals or humans have been performed
to elucidate the pathogenesis of this pathotype. Data from
these in vitro, in vivo and ex vivo experiments strongly indi-
cate that EAEC can bind to jejunal, ileal and colonic epithelium
in the characteristic aggregative pattern, forming a strong
bioﬁlm in a mucus layer, followed by cytotoxic and proinﬂam-
matory effects.260,266–270 Fragments from terminal ileum and
colon excised from pediatric and adult patients were incu-
bated with EAEC strains that were capable to colonize the ileal
and colonic mucosa in the typical stacked-brick pattern over
an augmented mucus layer.270
All these lines of evidence in combination with the iden-
tiﬁcation of several putative virulence factors in prototype
EAEC strains allowed the proposal of a three-stage model of
EAEC pathogenesis: (a) abundant adherence to the intestinal
mucosa, (b) production of cytotoxins and enterotoxins, and
(c) induction of mucosal inﬂammation.211 In the ﬁrst stage,
the contribution of ﬁmbrial and aﬁmbrial adhesins as well
as other adhesive structures is essential. Several colonization
factors have been identiﬁed in EAEC strains.271 In this stage, a
characteristic increased secretion of mucus on the intestinal
mucosa leads to the formation of a strong bioﬁlm where EAEC
are embedded.234,266,272 In the following step, EAEC produce
cytotoxic effects on the intestinal mucosa due to the secretion
of toxins, inducing microvillus vesiculation, enlarged crypt
openings, and increased epithelial cell extrusion.266,273 EAEC-
induced inﬂammation results from the strong colonization
of the intestinal mucosa; however, all bacterial factors that
contribute to this condition have not been identiﬁed. Inﬂam-
matory markers such as IL-8, IL-1, interferon (INF)-  and
lactoferrin have been detected in stools of children and adults
colonized by EAEC.274–276 Although this model summarizes
the data so far obtained using in vivo, in vitro and ex vivo
approaches it may not be valid for all strains.
A large foodborne outbreak of bloody diarrhea and HUS
occurred in 2011 in Europe, affecting more  than 4000 patients,
most of them from Germany. This outbreak was caused
by a Stx2-producing E. coli strain belonging to the serotype
O104:H4. The genome of that strain was rapidly sequenced,
revealing a unique hybrid combination of EAEC and STEC,
i.e. the EAEC strain Ec55989 harboring the Shiga toxin 2-
encoding prophage.166,213 Several virulence factors of typical
EAEC are present in that strain, including AggR, dispersin, Pic b i o l o g y 4 7 S (2 0 1 6) 3–30
and ShET-1. Also expressed are two Shigella autotransporter
proteins called SigA and SepA, implicated in mucosal dam-
age and colonization.277,278 Interestingly, the EAEC Ec55989
is the prototype strain for AAF/III.237 Conversely, the out-
break hybrid strain produces AAF/I, showing that the outbreak
EAEC/STEC acquired an AAF/I-encoding plasmid.166,279 It has
been proposed that the presence of these virulence factors
combined is responsible for the highly virulent attributes of
that strain.166,213
Epidemiology
EAEC is an emerging pathogen affecting children and adults
worldwide, responsible for cases of acute and persistent diar-
rhea. Nevertheless, the most important impact in terms of
morbidity is among children younger than 5 years living in
developing countries.214 A meta-analysis study of the lit-
erature on the epidemiology of diarrhea that included the
search of EAEC showed a statistical association of EAEC with
acute and persistent diarrhea in developed and developing
countries, with diarrhea in HIV-infected patients in developing
countries, and adult traveler’s diarrhea.280 In another meta-
analysis study EAEC was associated with acute diarrhea in
children living in South Asian countries.281
It is important to mention that data on the epidemi-
ology of EAEC infection are somewhat inconsistent due to
large variation in terms of method of detection, geographical
location and patient age and socioeconomic status. Nonethe-
less, EAEC has been systematically identiﬁed as an emerging
enteropathogen, strongly associated with acute and persis-
tent diarrhea in children of developing countries. Moreover, in
developed countries, EAEC have been frequently isolated from
cases of diarrhea in children and adults in the last years.282,283
In addition, several foodborne outbreaks of diarrhea caused
by EAEC have been reported in Europe, Japan, Mexico and
India.231,232,284–286 One of them affected 2697 school children
in Japan, after consumption of school lunches.232
Several studies have implicated EAEC as the predominant
agent of persistent diarrhea in children.287–289 EAEC-mediated
persistent diarrhea has been linked to malnutrition and
decrease in physical and intellectual development in several
studies from Brazil.274,288,290 Notably, asymptomatic patients
infected with EAEC also exhibit growth retardation.274 Since
its deﬁnition as a pathotype, high rates of asymptomatic
young children carrying EAEC have been reported in sev-
eral studies, involving subjects with low socioeconomic status
in developing countries.214 The persistence of EAEC may
induce chronic intestinal inﬂammation, even in the absence
of diarrhea, reducing its absorptive function and leading
to malnutrition.274,291 Growth impairment has also been
observed in a mouse model of EAEC oral infection.292 Consid-
ering the high number of asymptomatic EAEC-colonized
children in low-income countries, this pathotype has an
important impact on public health as one cause of impaired
physical and cognitive development.
EAEC is transmitted by the fecal-oral route by food or con-
taminated water.232,285,286 EAEC were detected in milk samples
from infant feeding bottles that were handled by mothers
with low socioeconomic status.293 Also, viable EAEC were
isolated in tabletop sauces from Mexican restaurants.294 No
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elationship has been found between EAEC strains isolated
rom humans and different animal species, indicating that
nimals may not represent a reservoir of human pathogenic
ypical EAEC.295
EAEC has also emerged in the last years as an agent of uri-
ary tract infections (UTI). Initially, Abe et al.,296 described the
resence of EAEC virulence markers in strains isolated from
TI, which was subsequently observed by others.297–300 Also,
he presence of uropathogenic E. coli (UPEC) markers in EAEC
ollections has been reported.301,302 These ﬁndings pointed
ut the potential for some EAEC strains to cause UTI.
A community acquired UTI outbreak caused by an EAEC
train of serotype O78:H10, occurred in Denmark.303 This mul-
iresistant strain belonged to the multilocus sequence type
T10 and phylogenetic group A. This was the ﬁrst time that
AEC was implicated as an agent of an outbreak of extrain-
estinal disease. The uropathogenic properties of this EAEC
train were conferred by speciﬁc virulence factors, such as
he AAF/I ﬁmbriae.304 Recently, EAEC was implicated as a
ausative agent of one case of urosepsis.300
etection  and  diagnosis
mong the DEC pathotypes, EAEC is the most difﬁcult to cat-
gorize, since it is a very heterogeneous group. The deﬁning
haracteristic of EAEC is the AA pattern in human epithelial
ells or on a glass substrate in a distinctive stacked-brick for-
ation. Thus, the gold standard method for distinguishing
AEC is to culture ﬁve E. coli colonies per patient in static Luria-
roth at 37 ◦C, and then to infect semi-conﬂuent HEp-2 cells
or 3 or 6 h, looking for the typical AA pattern.212,305 However,
his test requires specialized facilities and is time-consuming,
estricting its use only to research and certain reference labo-
atories.
Furthermore, despite that several protein components
uch as Pic, ShET1, EAST-1, and Pet are involved in the vir-
lence of EAEC, none of them is present in all isolates. The
resence of Pet in EAEC isolates was initially detected by
mmunoblotting assays after a preliminary step of culture
upernatant concentration.256 Vilhena-Costa et al.306 devel-
ped a slot blot immunoassay that avoids the concentration
tep, allowing the detection of Pet directly from EAEC super-
atant, after growing the EAEC bacterial isolate in TSB at
7 ◦C for 4 h. In this method, it was possible to evaluate Pet
xpression with speciﬁcity and reproducibility, using a rabbit
olyclonal anti-Pet serum, which showed no cross-reaction
ith supernatants of non-Pet-expressing isolates and com-
ensal E. coli.
Considering these difﬁculties, DNA probes were included
s a valuable tool for EAEC detection.307 After sequencing the
coRI-PstI fragment of pCVD432 (AA or EAEC probe) developed
y Baudry et al.,228 primers complementary to this probe for
CR ampliﬁcation were designed.308 This PCR assay was found
o be a rapid, simple, and highly sensitive method, and there-
ore considered to be useful for screening stool specimens for
he presence of EAEC strains. Rapid and practical multiplex
CR assays targeting more  genes (aggR, aap and aatA, encod-
ng the AggR regulator, dispersin and an ABC secretion system
uter membrane protein, respectively) or aggR, pic and astA,
ncoding AggR, Pic and an EAST-1) have also been employed to i o l o g y 4 7 S (2 0 1 6) 3–30 13
detect EAEC strains.309–311 Monteiro et al.248 used PCR to evalu-
ate aggR, aatA and aap in a collection of E. coli strains and found
that aggR and aatA were more  speciﬁc to EAEC than aap, sug-
gesting that the simultaneous detection of aggR, aatA, and aaiA
(a type VI secretion system protein) could be an improvement
in the PCR detection of EAEC.
All these proposed PCR-based protocols detect plas-
mid  genes, which disfavors the detection of atypical EAEC
strains.305,309,312 Others, employing plasmid and chromosome
loci, have not reported sensitivity and speciﬁcity of the
assay.226,313,314 However, a multiplex PCR based on two  genes
encoded in the plasmid and two chromosome-borne genes
is recommended to increase the ability to detect both typi-
cal and atypical EAEC strains. The aggR and aatA genes309,313
and aaiA and aaiG genes315 incorporated in the assay detec-
ting aaiA, aaiG, aggR and aatA demonstrated 94.8% sensitivity
and 94.3% speciﬁcity, and the assay was able to effectively
detect both groups of EAEC among E. coli isolated from stool
cultures.316 This method should improve EAEC detection,
since this pathotype is responsible for acute and persistent
diarrhea in children and adults and is also associated with
foodborne diarrheal outbreaks.
Enterotoxigenic  E.  coli
ETEC strains are characterized by the production of coloniza-
tion factors (CFs) and at least one of two enterotoxins: LT and
ST. ETEC represents one of the most common causes of diar-
rhea in children in developing countries and in travelers to
these regions. ETEC is also an economic burden to farmers and
industry, where it is an important pathogen for broilers, swine,
cattle and other farm animals. The group represents a highly
diverse pathovar of diarrheiogenic E. coli, harboring mobile
genetic elements such as plasmids and phages. ETEC hetero-
geneity was ﬁrst demonstrated by phenotypic traits including
the large diversity of lipopolysshacaride (LPS) and ﬂagelin
composition and the expression of different CFs and toxin
types.317,318 Serological typing of ETEC strains have relied on
the composition of outer membrane proteins and, mainly, in
the somatic LPS (O) and ﬂagellar (H) antigens.318–320 ETEC com-
prise more  than 100 somatic serogroups (O) and at least 34
ﬂagellar types (H), combined in an unpredicted number of
O:H serotypes, but only a limited number of serotypes are
associated with infectious diseases, such as O8:H9, O6:H16,
O78:H12 and O25:H42, and are therefore of major clinical
relevance.318,321
The genetic diversity of ETEC has also been evaluated
by molecular approaches including random ampliﬁcation of
polymorphic DNA (RAPD), MLEE, PFGE, multilocus sequence
type (MLST) and whole-genome sequencing.322–330 More
recently, 362 human-derived strains were subjected to next-
generation whole-genome sequencing; 21 genotypes could
be identiﬁed, and ETEC strains could be classiﬁed into
5 major phylogroups (A, B1, B2, D and E).330 Genetic
analyses demonstrated that clonally related ETEC lineages
sharing the same serotypes and CF and toxin proﬁles
have worldwide distribution.327,328,330–332 On  the other hand,
genetically distinct ETEC strains, frequently found among
asymptomatic subjects show high antigen heterogeneity with
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regard to virulence traits and serotypes.333 Apparently, these
strains have recently acquired the genes encoding virulence-
associated traits, and their maintenance is driven by selective
pressure.328,330
Virulence  factors,  mechanisms  and  pathogenesis
Following the initial discovery of the association of ETEC with
diarrheic disease in humans in the 1950s, there was an intense
effort to identify ETEC virulence-associated traits that could
help to understand the physiology of the pathological process
and lead to the development of speciﬁc diagnostic meth-
ods. ETEC strains characteristically produce adhesins, or CFs,
proteinaceus complex that may take the shape of ﬁmbrial,
ﬁbrillar or nonﬁmbrial structures on the bacterial surface. The
adhesins expressed by ETEC strains facilitate the adherence
of the bacteria to the intestinal mucosa and confer host speci-
ﬁcity to the different strains.317,321
Approximately 30 antigenically distinct CFs have been
identiﬁed in clinically relevant ETEC strains, but only a few
are usually found among samples collected from diarrheic
patients.317,330 Besides differences regarding biogenesis and
structural organization, ETEC CFs show speciﬁc antigenic,
genetic and biochemical features, which are currently used to
cluster them into three main groups: the colonization factor
antigen I (CFA/I)-like group, the coli surface antigen 5 (CS5)-like
group and the class 1b group.317,334,335 The CFA/I-like group
harbors the ﬁrst described CF (CFA/I) and some of the most
clinically prevalent CFs, including CS1, CS2, CS4, CS14, CS17,
CS19 and putative colonization factor O71(PCFO71), while the
CS5-like group comprises only CS5 and CS7. The class 1b group
includes CS12, CS18, CS20 and the recently described CS26-
28 and CS30 types.317,334,335 Additionally, genetic relationships
are also observed between strains expressing CS8 and CS21,
CS13 and CS23, as well as between strains expressing CS15
and CS22.336–338 Other previously characterized CFs, such as
CS3, CS6, CS10 and CS11, are not classiﬁed into the known CS
families.317 Some CFs, such as CS18 and CS20, are related to
swine-derived ETEC ﬁmbriae, which show a lower heterogene-
ity than those found in strains isolated from humans.317,321,339
Strains expressing CFA/I, CFA-II (CS1/CS3, CS2/CS3 or CS3),
CFA-IV (CS4/CS6, CS5/CS6 or CS6), CS17 and/or CS21 are the
most prevalent CFs found in epidemiological studies, whereas
other CFs are found in ETEC strains not clearly linked to diar-
rheal disease.317,318,331
After adherence to the intestinal mucosa, ETEC strains
produce enterotoxins, which are recognized as the second
component associated with diarrheal disease. Two major cat-
egories of enterotoxins have been identiﬁed among ETEC
strains, isolated either from humans or other animal hosts: LT
and ST. Both toxin types mediate deregulation of membrane
ion channels in the epithelial membrane, leading to the loss of
ions and massive amounts of water, the major characteristic
of watery diarrhea caused by these bacterial strains.340
LT are composed of ﬁve identical monomers (11.5 kDa)
arranged in a ring shape to form a pentameric B subunit, and
a 28-kDa A subunit linked to the B subunit by the helical A2
domain. The B subunit binds to cell surface receptors, par-
ticularly to gangliosides, promoting toxin internalization and b i o l o g y 4 7 S (2 0 1 6) 3–30
retrograte transport up to the endoplasmic reticulum, where
the A1 domain is cleaved from the A2 domain and released
to the cytoplasm. The A1 domain transfers the ADP-ribose
moiety from the NAD+ cofactor to stimulatory G protein,
which becomes active and capable of stimulating adenylate
cyclase, leading to an intracellular increase in cyclic adenosine
monophosphate (cAMP). Higher cAMP levels in the cell induce
protein kinase A activation, which in turn leads to phos-
phorylation of ion channels, resulting in Cl− release as well
as decrease in Na+ uptake and, consequently, massive water
release to intestinal lumen, the major characteristic of secre-
tory diarrhea caused by these pathogens.6,341 ST, a monomeric
protein of about 5 kDa, may also induce osmotic deregula-
tion, activating directly the guanylate cyclase C located at the
apical membrane of the intestinal cells to produce intracel-
lular cyclic guanosine monophosphate and consequently to
generate secretion of Cl− ions and water from the intestinal
epithelium. However, an ST variant ﬁrst isolated from pigs
shows distinct physiological activity, characterized by the loss
of villus epithelial cells and net bicarbonate secretion.6 The
toxins LT and ST, separately or in combination, are able to
induce cellular water-electrolyte imbalance, which surely con-
tributes to ETEC pathogenesis.
A hallmark in ETEC biology is the expression of enterotox-
ins, which also display a signiﬁcant antigenic heterogeneity.
Approximately one-third of the strains isolated from diar-
rheic patients express only LT or only ST, while another
third express both toxin types. In addition, two unrelated
ST groups, with different functional and structural features,
have been identiﬁed: (i) STa, comprising two variants (STh
and STp) associated with human disease, and (ii) STb, which
is generally found among swine-derived ETEC strains. Simi-
larly, LT are divided into two antigenically distinct groups: LT-I
and LT-II.6 Initially, two LT-I variants, isolated from human
or swine-derived ETECs (LTh and LTp, respectively), were
described and shown to have high amino acid sequence iden-
tity and similar but not equal antigenicity and biochemical
and receptor-binding properties.342,343 The related LT-II vari-
ants (LT-IIa,-IIb,-IIc) have been isolated from human beings
or other hosts and contaminated food and bind to different
receptors.344–347 The LT-IIa, LT-IIb and LT-IIc share 51, 52 and
49% or 15, 16 and 7% identity with LT-Ih regarding the A and B
subunits, respectively.347,348
More recently, a pioneer study carried out with ETEC strains
isolated in Brazil demonstrated a rather high intraspeciﬁc
LTh variability between LT-producing ETEC strains.333,349,350
In a collection of 51 ETEC strains expressing LT and/or ST,
50 genetic polymorphic sites were found in the LT-encoding
genes, which revealed 16 natural LT variants according to
differences in amino acid sequences. Among these variants,
named LT1 to LT16, two (LT1 and LT2) were associated with
a limited number of serotypes with a global distribution and
mainly isolated from diarrheic patients.333 In contrast, most of
the detected LT variants were observed among LT-producing
ETEC strains isolated from asymptomatic subjects.333 More
recently, 12 additional LT types were identiﬁed in a larger col-
lection of ETEC strains isolated from different regions of the
world.351 Interestingly, a much reduced genetic variability was
found in the LT-encoding genes among ETEC strains isolated
from pigs (LTp) and ST-encoding genes.352,353
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The natural diversity of LT types found among ETEC strains
solated from symptomatic and asymptomatic humans sug-
ests that some LT types can show higher toxicity to
ukaryotic cells and can be expressed at different levels com-
ared to other toxin types. Indeed, previous observations
ndicated that some LT types are endowed with different tox-
city, under in vitro and in vivo conditions.333,349,350 A natural LT
ariant, similar to the LT expressed by swine-derived strains,
howed reduced toxicity due to an amino acid replacement at
 key polymorphic site in the A subunit.333,350 This amino acid
hange provided a less ﬂexible A subunit structure, impairing
ppropriate contact with the cofactor (NAD+) at the catalytic
ite.350 Other authors observed that natural polymorphisms
n the B subunit resulted in decreased receptor binding and
herefore reduced toxicity to eukaryotic cells.352 These results
uggest that the presence of ETEC strains expressing differ-
nt LT variants may correlate with the incidence of symptoms
mong infected subjects, particularly among infected infants
ot previously exposed to ETEC infections.
Variable LT expression may also impact the severity
f ETEC-associated disease. Previous observations demon-
trated that the amounts of LT produced and/or secreted
y ETEC are dramatically different among strains and clin-
cal isolates.332,351,354–356 The presence of single nucleotide
hanges in the etx operon regulatory region may be found
nd, at least for some of them, are associated with dif-
erent transcriptional and translational activity among wild
TEC strains.332,unpublished data Nonetheless, further studies are
equired to demonstrate a clear link between transcriptional
nd post-transcriptional events and the severity of the symp-
oms associated with ETEC infection.
pidemiology
nnually, infections with different ETEC strains cause an
stonishing number of diarrheal episodes, greatly exceeding
00 million cases and causing approximately 75,000 deaths,
ainly among babies and young children in tropical areas
ith poor sanitary conditions.118,357 In Brazil, epidemiological
ata harvested at different times between 1978 and 2007 have
emonstrated that the incidence of ETEC-induced diarrhea
anges from 3.5 to 20.45%.115,358–361
etection  and  diagnosis
his pathotype is mainly characterized by the enterotoxins
t produces, and diagnosis depends upon identifying either
T and/or ST. One or both toxins may be expressed by ETEC
trains.340,362–364 The diagnosis of ETEC strains should include,
n addition to LT and ST detection, complementary PCR assays
or the detection of virulence genes such as clyA, eatA, tia,
ibC, leoA, and east-1.340 A sensitive and speciﬁc PCR assay
ith primers targeting the genes lt and st was reported by
tacy-Phipps et al.,365 and later by Youmans et al.,366 using
uantitative real-time PCR. Moreover, several multiplex PCR
ssays were also developed using these two  genes.367–369Phenotypical detection of ETEC was initially performed
sing supernatants obtained from single E. coli colonies and
y laborious procedures such as rabbit ileal loop test,370 suck-
ing mouse assay371 or cytopathic effect studies on CHO or Y1 i o l o g y 4 7 S (2 0 1 6) 3–30 15
adrenal cell monolayers, in which the presence of LT in super-
natants was indicated by rounding of Y1 cells or elongation of
CHO cells after 24 h of incubation.372,373
A number of immunoassays have been developed for ST
detection, including radioimmunoassay and enzyme-linked
immunosorbent assay (ELISA). Both tests correlate well with
results obtained with the suckling-mouse assay and require
substantially less expertise.374,375 ELISA assays were then
developed using the GM1 receptor to bind LT obtained from
ﬁltered culture supernatants or employing a competitive test
for LT, which replaced former procedures.376
Immunological assays for LT detection includes the tradi-
tional Biken test, latex agglutination, and reliable and easy
to perform commercially available tests, such as the reversed
passive latex agglutination and the staphylococcal coagglu-
tination test.321 Several immunological assays where LT is
captured either by ganglioside GM1  (its receptor in the host
cell) or by antibodies have been described.139,321,377,378 Assays
for ST by indirect ELISA using IgG1 ST-mAb and for LT by
capture ELISA employing IgG enriched fraction of a rabbit poly-
clonal as a capture antibody and IgG2b LT-mAb as a second
antibody have been employed as tools for diagnosis. The pres-
ence of bile salts and the use of certain antibiotics improved
ETEC toxin production/release. Triton X-100, as chemical treat-
ment, proved to be an alternative method for toxin release.
Consequently, a common protocol that can increase the pro-
duction and release of LT and ST could facilitate and enhance
the sensitivity of diagnostic tests for ETEC.355 Afterwards,
those monoclonal antibodies were rebuilt resulting in sin-
gle chain fragment variable (scFv) fragments. The developed
recombinant scFvs against LT and ST constitute a promising
starting point for simple and cost-effective ETEC diagnosis.379
Enteroinvasive  E.  coli
Enteroinvasive E. coli (EIEC) is a causative agent of dysentery in
humans, especially in developing countries.380 It causes ker-
atoconjunctivitis in experimental guinea pigs381 and invades
human colon cells, causing an infection similar to that caused
by Shigella sp.382,383 The ﬁrst description of EIEC was per-
formed by EWING and GRAWATTI in 1947.384 The ﬁrst works
emphasizing the particular biochemical characteristics of EIEC
samples were presented in 1967 by Trabulsi et al.,385 in Brazil
and by Sakazaki et al.,386 in Japan. All isolates studied were
Serény test positive (guinea pig keratoconjunctivitis) and the
strains were lysine decarboxylase negative, late fermenting
lactose and generally non-motile, except for samples of the
O124 serogroup. The study of the biochemical behavior of
97 samples of EIEC381 corroborated the results obtained pre-
viously. It has been shown that this group of diarrheagenic
E. coli belonged to well-deﬁned bioserotypes, O28ac:H-, O29:H-,
O112ac:H-, O121:H-, O124:H-, O124:H30, O135:H-, O136:H-,
O143:H, O144:H-, O152:H-, O159:H-, O164:H-, O167:H- and
O173:H-.381,387–389 In 1964, it was demonstrated that samples
of the O32 and O42 serogroups of E. coli also had the abil-
ity to cause keratoconjunctivitis in guinea pigs.389 However,
the existence of enteroinvasive bioserotypes in O42  serogroup
was not conﬁrmed, and O32 bioserotype is actually an aero-
genic variant of S. boydii 14, as shown by Toledo et al.390 There
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are reports of isolation of EIEC samples belonging to other
mobile serotypes, O144H25391; however, these are sporadic
cases. Recently, the serotype of E. coli O96:H19 was described as
enteroinvasive E. coli in two large outbreaks occurring in Italy
and United Kingdom.392,393 It is worth mentioning that EIEC
serotypes considered to be nonmotile produce an unusually
large (77 kDa) ﬂagellin that is assembled into functional ﬂa-
gellum ﬁlaments that allow the bacteria to swim in modiﬁed
motility agar (0.2%).394 Analysis of the ﬂiC gene showed that
11 different EIEC serotypes have six molecular proﬁles of ﬂiC.
The major EIEC serotypes showed low ﬂiC diversity. The den-
drogram showed two major clusters, suggesting two different
origins for the ﬂagellin gene among these strains. In addition,
the presence of the same pattern among strains of the same
serotype suggests the existence of a common clone.395
Virulence  factors,  mechanisms  and  pathogenesis
Diarrhea due to EIEC and Shigella is caused by the invasion
and penetration of bacteria in the enterocytes, leading to their
destruction. These bacteria bind speciﬁcally to the mucosa
of the large intestine and invade cells by endocytosis.396,397
Shigella ﬂexneri strains are used as template for most studies
of invasion.
The complex process in colonization and EIEC survival in
the gastrointestinal barrier depends on the presence of a large
plasmid of about 220 kb (pInv), very similar to that found in
Shigella.397–400 In this process, multiple bacterial genes are
involved, both chromosomal and plasmidial. Bacteria with-
out the virulence plasmid do not cause keratoconjunctivitis
in guinea pigs, being considered non-virulent.397,401
Most of these functions are related to proteins encoded
by a 31-kb fragment from pInv, containing 38 genes. In this
fragment are genes responsible for bacterial invasion and
escape, by cell spreading, inhibition of autophagy, regula-
tion of immune response of the host apparatus and type III
secretion system (TTSS). Once injected into the host cell, the
virulence or effector factors induce or inhibit cell signaling
pathways. The changes in host cells induced by bacteria allow
intracellular survival of these microorganisms.402–404
Due to the great similarity between Shigella and EIEC, it can
be assumed that the two would share the same ancestor and
that at a given moment in evolution there was a division. Why
has EIEC retained some E. coli properties that have been lost in
multiple lineages of Shigella? Data obtained by different groups
lead to the speculation that EIEC strains are in an intermediate
stage and are a potential pre-cursor of “full-blown” Shigella
strains.405–409
Despite the similarities invasion mechanism and symp-
toms of the disease (dysentery), the infectious dose of EIEC
is much higher than that of Shigella.410 Furthermore, the dis-
ease caused by EIEC appears to be a milder and self-limiting
form.
In the Serény test, it was observed that EIEC induces a
milder form of the disease (mild/moderate inﬂammation),
while Shigella leads to an exacerbation of proinﬂammatory
response (severe inﬂammation). Furthermore, keratoconjunc-
tivitis develops more  rapidly in guinea pigs inoculated with
Shigella (two days) than in guinea pigs inoculated with EIEC
(4–5 days).411 b i o l o g y 4 7 S (2 0 1 6) 3–30
Samples from different serotypes of EIEC have shown poly-
morphism in some regions of genes involved in invasion.
However, the data reveal that there are no changes in genes
of the invasion plasmid antigens that could explain the differ-
ences in pathogenicity between Shigella and EIEC.400 Moreover,
recent studies from our group showed that the genes respon-
sible for cell spreading (icsA and icsB) and regulation of the
immune response of the host (osp) did not indicate changes
that could explain the difference in pathogenicity between
Shigella and EIEC (data not shown).
Another important aspect of bacterial colonization is the
uptake of iron (Fe) under conditions limited in the host. Iron
is an essential element for all living organisms, it is estimated
that the microorganisms require iron at concentrations from
10 to 10−6 M to meet their metabolic needs. It was shown that
EIEC has a high adaptability, using, if necessary, the iron cap-
ture system that consumes less energy. The ability to capture
Fe from different sources can facilitate the development of
infectious processes by this bacterium.412,413
EIEC, like other enteric pathogens, target M cells (micro-
fold cells) present in the intestinal mucosa as a route of
entry to deeper tissues of the host.403,414 Reaching the lam-
ina through the M cells, the bacterial cells are phagocytized by
macrophages and dendritic cells. These cells are the ﬁrst step
in the production of the inﬂammatory response against bac-
terial invasion. After escape from macrophages and dendritic
cells, EIEC are able to invade enterocyte cells from the baso-
lateral side, escaping from the phagosome and replicating in
the cytoplasm.403,414
Our group ﬁrst described the phenotypic and genotypic
characteristics explaining the lower capacity of EIEC to cause
disease when compared with the species of Shigella. To this
end, use has been made of experimental models that mimick
the intestinal microenvironment of the host, such as cul-
tures of intestinal epithelial cells, macrophages and dendritic
cells.411,415,416 Our results showed that the initial ability to
invade the intestinal cell is similar between EIEC and Shigella,
but that the expression of virulence genes (ipaABCD, icsA, icsB,
virF, virB), capacity to escape from the phagosome, intracel-
lular proliferation and dissemination of EIEC, as well as the
ability to cause cell damage during the infection, are much
lower than with S. ﬂexneri.411 A signiﬁcantly greater number
of EIEC are seen inside macrophages compared to Shigella
after phagocytosis. Furthermore, Shigella shows greater capac-
ity to escape from macrophages as compared to EIEC. The
expression of virulence genes, production of proinﬂammatory
cytokines and cell death was found to be less in macrophages
infected by EIEC when compared to Shigella. It should be noted
that the production of antiinﬂammatory cytokine IL-10 by
macrophages is greater in infection by EIEC than Shigella.415
EIEC interaction with dendritic cells has been evaluated.
The data suggest that EIEC induces the production of IL-10,
IL-12 and TNF- by infected dendritic cells, while S. ﬂexneri
induce TNF- production. Unlike Shigella, infection with EIEC
increases the expression of TLR-4 and TLR-5 receptors on
dendritic cells and decreases the expression of costimula-
tory molecules that may cooperate to induce the proliferation
of T-lymphocytes, and in addition, there is a greater prolif-
eration of lymphocytes challenged with S. ﬂexneri than with
EIEC.416
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pidemiology
he EIEC strains have similar biochemical, genetic and
athogenic characteristics as Shigella species, which can
ften make the correct identiﬁcation of this pathotype
ifﬁcult.381,385,386,417 Epidemiological data may be underesti-
ated due to the difﬁculty in differentiating between Shigella
nd EIEC.
EIEC was responsible for several outbreaks, but there are
ew reports on routes of transmission and distribution of
his bacterium in nature. Water and cheese were described
s potential sources,418–421 as well as the direct transmis-
ion through person-to-person contact.422 In the 1970s, a
ajor outbreak of diarrhea was reported in the United States,
hich affected 387 patients. The transmission vehicle was an
mported cheese, contaminated by O124 serogroup.419 Accord-
ng to the food and drug control agency of the United States
Food and Drug Administration-FDA), outbreaks caused by EIEC
ave been associated with milk and milk products and beef;
owever, any food or water contaminated with human feces of
n individual patient can cause disease in other individuals.423
n Brazil, there is a report of three samples isolated from
ater.421 Outbreaks involving two EIEC were recently reported
n Europe, one in Italy in 2012 involving 109 cases and another
n the United Kingdom in 2014 involving 50 cases.392,393 In
oth, vegetables were to blame.
In Calcutta, the prevalence of EIEC in a group of 263 patients
ospitalized with diarrhea was high, 16.3% of cases.424 How-
ver, there are reports of a prevalence of 2%.425 In Thailand,
hina and other Asian countries, a prevalence of 4 to 7%
as been seen.426–429 In Bolivia, the reports showed a 2%
revalence.430 Some studies have shown that in Nigeria, Iran
nd Thailand, the distribution of EIEC is below (less than
.1%) the rates found in developed countries; in Spain, for
xample, a prevalence of 0.2% was found.431–434 The low inci-
ence can be due to difﬁculties in differentiating EIEC from
higella.
The isolation of EIEC in Brazil has ranged from 0.5 to 15%,
epending on the population investigated.435–440 The data sug-
est that the presence of EIEC is related to socioeconomic
onditions. Toledo and Trabulsi439 investigated the presence
f this microorganism from children under ﬁve years of age
nd non-slum-dwelling children from different areas of the
ity of São Paulo. This bacterium has been found in 17 of
07 slum-dwelling children with diarrhea (15.9%) and in 16 of
01 non-slum-dwelling children with diarrhea (2.3%). In the
rst group, EIEC was the enteropathogen most frequently iso-
ated from children over 2 years of age. In non-slum-dwelling
hildren of the same age, it was the fourth most common
gent, being more  frequent than EPEC, Salmonella,  Rotavirus,
nd Yersinia enterocolitica. Studies performed outside the city
f São Paulo showed a low prevalence of these bacteria,
.5–2.5%.435,440
etection  and  diagnosisamples of EIEC grow well in culture medium routinely used
or isolation of Enterobacteriaceae, such as MacConkey agar,
ylose-lysine-deoxycholate (XLD) agar and Hektoen enteric
HE). Highly selective media such as Salmonella Shigella agar i o l o g y 4 7 S (2 0 1 6) 3–30 17
(SS) or bismuth sulﬁte agar may not be as effective for some
serotypes.381
The identiﬁcation of E. coli species may be carried out
using conventional biochemical tests, such as production
of indole, fermentation of glucose, sucrose and lactose, gas
production from glucose fermentation, pathway glucose fer-
mentation, using citrate as sole carbon source, motility, lysine,
arginine and ornithine decarboxylation.1,441 Fermentation of
lactose varies according to the strain; EIEC samples can fer-
ment lactose slowly (72 h), making it difﬁcult to differentiate
from Shigella.381 Complementary to the physiological and bio-
chemical characteristics, serotyping may be required for the
differentiation, since some serotypes of S. ﬂexneri produce
indole. In such cases, O antisera of EIEC and Shigella should
be used.1,441 Bacterial colonies with this characteristic can
be screened for the classical EIEC serogroups O28ac, O29,
O112, O124, O136, O143, O144, O152, O159, O164, O169, and
O173.1,441,443 EIEC invasive capacity can be evaluated using
the Sereny guinea pig eye test444 and tissue culture assays,445
which are more  markedly limited to reference laboratories.
To characterize the EIEC pathotype, it is necessary to search
for plasmid virulence genes. Currently, the investigation of
the ipaH gene, a multi-copy gene (4–10) present in EIEC and
Shigella, by PCR is recommended,442,446 or studies of other
DNA sequences are needed, such as the invasion-associated
locus gene (ial).447 The presence of the iudA and lacY genes
can differentiate EIEC from S. ﬂexneri.446 A simple and rapid
stool test based on apyrase (ATP-diphosphohydrolase) activ-
ity was described for EIEC detection.448 This is an essential
periplasmic enzyme required for unipolar localization of IcsA,
which is involved in the pathogen’s intracellular and inter-
cellular spread, and is only expressed by EIEC and Shigella.449
The enzyme activity is measured by a colorimetric reaction.
The method is robust, requires widely available equipment
and affordable reagents, and can be applied for routine use in
laboratories with limited resources.448
Conclusions
The genomic plasticity of E. coli strains is noteworthy, as can
be seen by the variety of strains ranging from commensal
residents of the gastrointestinal tract to assorted pathogens
that are able to promote intestinal or extraintestinal illnesses
with different clinical consequences. It is thus important to
note that the continuous evolution of the E. coli genome has
hindered the classiﬁcation of certain E. coli isolates into a
pathotype, because some isolates combine the main virulence
characteristics of different pathotypes and are thus consid-
ered hybrid pathotypes (reviewed in 5) with the potential of
allowing the rise of new and more  virulent pathogenic E. coli
hybrids.
Whole-genome sequencing has provided a great amount
of useful information on the genome of pathogenic E. coli,
which will help improve diagnosis, typing, disease manage-
ment, epidemiology and outbreak investigations as well as
helping to monitor the spread of pathogens.5 Despite the
recent advances in our knowledge of the genetic background
and pathogenicity of strains of different DEC pathotypes, var-
ious novel genes encoding unknown functions are yet to be
 i c r o
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characterized to further our understanding of the interactions
of these pathogens with their hosts.
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